No more 15 minutes.if.they.are not.mentioning it! That is what you always have to watch out for with these penny "riches" stocks and their wild claims that make them seem especially valuable. They simply will stop talking about one of them from time to time and that means the claim is no longer valid. Its a read between the lines kind of thing. Essentially there is a minimal benefit to their tech over well established companies with market share and distribution channels/direct representation like Storz or Olympus! In my opinion! The stock is junk.
Good post on hammering @ the current industry standard of care. We appear to be @ the beginning of the USA rollout. It seems to me, Jim Hutchens took the reins while Kilmer Lucas tries to get it's act together. Let's see how IMEXF is doing in the coming weeks. The Polar Vortex got a lot of folks brain stuck on freeze mode.
To my knowledge Jim has never stated what the dwell time turned out to be in the 10 patient study. That poses a serious hesitation for me. And you may recall they stated 15min would be the slowest and if met would shoot for 10min then 7min. Not a word about meeting the dwell time goals.
The size of the endoscope mkt is irrelevant to what Imagin can expect. Can't tie the two together tightly.
There are 173M shs out not 140M. They will need more cash and issue more very low priced shs and screw the holders again.
They are so behind in their schedule. 12mos will not be met for prod.
Messing was supposed to publish a complete report on the 10patient study. He has never done that. WHY????????
News 
Market Data 
Discover 
